GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Contract Win

21 Jul 2009 09:21

RNS Number : 0059W
ViaLogy PLC
21 July 2009
 



ViaLogy plc ("ViaLogy")

ViaLogy joins with University of Texas and a large Texas Oil Independen

to analyze oil prospect

LondonJuly 21, 2009Vialogy (LSE: VIY) ViaLogy announces that it has signed a services contract with a large privately owned oil Independent based in MidlandTexas. The company drills over 40 wells per year.  Under this contract ViaLogy will provide reservoir sizing and drilling recommendations for an 11,000 feet deep Strawn formation prospect located in the Midland Basin in the heart of the Wolfberry play. The Wolfberry is currently one of the most active plays in the Permian basin. For competitive reasons the firm has declined to be publicly identified or to provide further project details.

According to the company's Chief Geophysicist"The Strawn formation is one of the more enigmatic hydrocarbon producing stratigraphic formations, as production rates can vary significantly over small regions. Well completion costs are high and we need more innovative computational approaches to characterize the subsurface and develop drilling targets. We are looking forward to ViaLogy's QuantumRD technology to assess subtle porosity variations and size hydrocarbon deposits on our block to mitigate risk."

ViaLogy will be collaborating on this project with seismic expert Prof. Bob Hardage and his geophysics team at the world renowned Bureau of Economic Geology (BEG) at the University of Texas at Austin. Prof. Hardage founded the Exploration Geophysics Laboratory (EGL) (http://www.beg.utexas.edu/indassoc/egl) currently focused on the development and application of multi-component seismic imaging. He has also collaborated with this independent in surveying and analyzing this prospect in the past. Bob Hardage commented, “We are very interested to apply ViaLogy technology to deliver better formation characterization from high quality 3D seismic and multi-component seismic surveys for tight sand-shale sequences. Results could have broad applicability in developing numerous reservoir systems”.

ViaLogy's deliverables will include characterization of hydrocarbon reservoir boundaries, subsurface formations, lithology, and depth, as well as porosity estimates, and recommended drill locations. 

ViaLogy CEO Robert Dean stated, "This is a significant and challenging opportunity to demonstrate our technology with a key independent, and to work hand-in-hand with the prestigious BEG in areas where conventional seismic analysis has proven to be limited. A successful outcome will move us closer to our goal of widespread industry acceptance of QuantumRD. At that point, we will be free to disclose the client and detailed results from the work. Multi-component seismic data is being increasingly collected by the E&P players for high thrust and carbonate reservoirs. Extracting more information from multi-component seismic opens up several new business opportunities for ViaLogy".

Further information from:

ViaLogy

Robert W Dean, President & CEO - US +1 626-296-6337 (mobile: +1 703-589-3807)

Terry Bond, Chairman - UK & Europe +44 (0) 1235-834734 (mobile: 07860 842756) 

Nominated Advisor to ViaLogy PLC (Seymour Pierce)

Mark Percy +44 (0) 20-7107-8000 

About ViaLogy: Network Centric Signal Processing

ViaLogy is a leading innovator of network-centric, real-time signal processing platforms for sensor applications. ViaLogy is currently deploying and designing computational systems, powered by its patented technologies, for applications in life sciences, public safety and security, surveillance, defense and geoseismology. ViaLogy focuses on market driven problems where automation, timeliness, quality and reliability of information processing are essential. ViaLogy's core competency incorporates rapidly and accurately detecting weak signals buried in high noise background and clutter. This technology can be employed to solve problems involving sensor integration and information overload challenges involving video, telephony and control sensors, as well as for enhancement of numerous signal processing applications. For more information, visit our website at www.ViaLogy.com.

Except for statements of historical fact, the information presented herein constitutes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTSEASAFSUSEFW
Date   Source Headline
1st Apr 201912:12 pmRNSHolding(s) in Company
25th Mar 20197:00 amRNSYourgene raises IONA® test awareness in Egypt
26th Feb 20193:21 pmRNSHolding(s) in Company
22nd Feb 201910:00 amEQSHardman & Co Research: Yourgene Health (YGEN): EBITDA-positive in fiscal 2020
22nd Feb 20198:05 amRNSHolding(s) in Company
19th Feb 20192:21 pmRNSHolding(s) in Company
19th Feb 20197:15 amEQSHardman & Co Research: Yourgene Health (YGEN): Transformed and de-risked
18th Feb 201910:59 amRNSIssue of Equity
18th Feb 20197:00 amRNSMajor Capital & Commercial Restructuring
8th Jan 20197:00 amRNSYourgene launches Sage 32 plex
3rd Dec 20187:00 amRNSHalf-year Results
7th Nov 20187:00 amRNSChange of Name to Yourgene Health plc
5th Nov 201811:24 amRNSShare Transfer
2nd Nov 20187:00 amRNSDirectorate Change
25th Oct 20183:30 pmRNSResult of AGM
25th Oct 20187:00 amRNSHolding(s) in Company
25th Oct 20187:00 amRNSAGM Statement
22nd Oct 20187:00 amRNSFurther re: Fundraise
12th Oct 20181:15 pmRNSAvailability of Research Commentary
12th Oct 20187:00 amRNSTrading Update and Notice of Results
5th Oct 20187:00 amRNSDirector's dealing and share option issue
4th Oct 20187:00 amRNS$1 million collaboration agreement
3rd Oct 20187:00 amRNSDirectorate change
2nd Oct 20187:00 amRNSNotice of AGM
1st Oct 201812:20 pmRNSResult of Fundraise
28th Sep 20185:41 pmRNSProposed fundraise to raise approximately £2.5m
28th Sep 20185:40 pmRNSFull year results and half-year trading update
25th Sep 201811:31 amRNSHolding(s) in Company
21st Sep 20184:10 pmRNSHolding(s) in Company
21st Sep 20187:00 amRNSHolding(s) in Company
20th Sep 20189:30 amRNSSenior Appointment & Anticipated Director Change
19th Sep 201811:05 amRNSSecond Price Monitoring Extn
19th Sep 201811:00 amRNSPrice Monitoring Extension
19th Sep 20187:00 amRNSLegal Settlement & Licence Agreement with Illumina
11th Sep 20187:00 amRNSHolding(s) in Company
7th Aug 201810:57 amRNSHolding(s) in Company
12th Jul 20187:00 amRNSShare option awards
4th Jul 20187:00 amRNSBoard Changes
26th Jun 20181:31 pmRNSCollaboration with Abnova
13th Jun 20187:00 amRNSOutstanding NIPS Solution Provider Award Win
11th Jun 20187:00 amRNSDNA sequencing technology development agreement
7th Jun 20183:44 pmRNSHolding(s) in Company
5th Jun 20187:00 amRNSPremaitha signs partnership agreement in India
4th Jun 201811:05 amRNSHolding(s) in Company
24th May 20187:00 amRNSHolding(s) in Company
18th May 20184:38 pmRNSHolding(s) in Company
18th May 201812:06 pmRNSHolding(s) in Company
18th May 201812:05 pmRNSHolding(s) in Company
18th May 20189:40 amRNSHoldings in Company
15th May 20187:00 amRNSPremaitha expands footprint with new laboratories

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.